Agarikon Mushroom: Ancient Remedy and Modern Antimicrobial Research

Agarikon (Fomitopsis officinalis, also reclassified by some mycologists as Laricifomes officinalis) is one of the rarest medicinal mushrooms sold today. It has a long history of use in European and Pacific Northwest traditional medicine, and small laboratory studies have found antimicrobial and antiviral activity against several bacteria and viruses. No published human clinical trials have tested agarikon, so its traditional reputation is far ahead of the science that has confirmed it.

Important Safety Notes Before You Read Further

A few points matter more than anything else in this article.

Authenticity is a real concern. True agarikon is endangered in the wild and very hard to cultivate. Products labeled “agarikon” may contain small amounts of the real fungus, mycelium grown on grain, or may be mislabeled entirely. There is no simple way for a consumer to verify what is actually in a bottle.
No human safety or dosing data exists. Because no clinical trials have been done, there is no established safe dose, no known interaction profile, and no data on long-term use in people.
Supplements are not reviewed by the FDA before they reach store shelves. The National Center for Complementary and Integrative Health (NCCIH) notes that manufacturers, not the FDA, are responsible for ensuring supplement safety before marketing.
This article does not recommend using agarikon. It explains what has and has not been studied so you can have an informed conversation with a qualified health care provider.

What Is Agarikon? A Brief History

Agarikon is a wood-decay fungus that grows as a large, hoof-shaped or column-shaped growth on conifer trees, mostly larch, fir, and other old-growth conifers. Mature specimens can grow to more than two feet long and weigh many pounds. It is slow-growing and needs old, undisturbed forest to thrive, which is why it has become scarce.

Historical accounts describe agarikon being used in ancient Greece as far back as the first century for respiratory complaints, including what was then called consumption (an old term for tuberculosis). In Europe, it earned the nickname “quinine conk” for its intensely bitter taste, though the mushroom does not actually contain quinine or true antimalarial compounds; that association was a folk misunderstanding, not a proven property.

In the Pacific Northwest of North America, Indigenous communities used agarikon in ceremonial and medicinal contexts, including carving fruiting bodies into ceremonial masks. This long, cross-cultural history is one reason mycologists have taken renewed interest in studying it, but historical use is not the same thing as clinical proof.

What the Research Shows: Antimicrobial and Antiviral Findings

Modern interest in agarikon accelerated after mycologist Paul Stamets, working with academic laboratory collaborators, began screening extracts from rare polypore mushrooms, including agarikon, for antimicrobial activity. It is important to separate what has actually been tested from what has only been proposed as a future possibility.

Laboratory (in-vitro) findings

A published laboratory study evaluated agarikon extracts against pox-family viruses (including cowpox, a common laboratory stand-in for studying poxviruses) and reported antiviral activity in cell culture.
Other laboratory screening has reported activity against herpes simplex viruses and influenza strains in cell culture, and against the bacteria that cause tuberculosis, with researchers identifying novel chlorinated coumarin compounds as possible active ingredients.
These are early-stage, test-tube (in-vitro) results. They show that isolated compounds can affect viruses or bacteria in a laboratory dish. They do not show that eating or taking agarikon can prevent or treat an infection in a living person.

What has not been studied

No animal studies establishing safe or effective doses have been published in peer-reviewed journals.
No human clinical trials of any kind (safety, dosing, or effectiveness) have been conducted or registered.
No data exists on how agarikon compounds behave once ingested, whether they are absorbed, or whether typical supplement processing preserves the compounds tested in the lab.

The National Cancer Institute’s overview of medicinal mushrooms, which covers species with far more research behind them (turkey tail, reishi, shiitake, maitake), illustrates the gap: those mushrooms have decades of laboratory work behind them plus a body of actual human trials. Agarikon has the laboratory work, but not yet the human trials. (See the National Cancer Institute’s medicinal mushrooms overview.)

Evidence at a Glance

Antiviral activity against pox-family viruses: Laboratory (in-vitro) evidence only. Seen in cell culture; not tested in animals or people.
Antiviral activity against herpes and influenza strains: Laboratory (in-vitro) evidence only. Preliminary lab screening with no confirmatory human data.
Antibacterial activity against tuberculosis-causing bacteria: Laboratory (in-vitro) evidence only. Specific compounds identified, but only tested outside a living organism.
Traditional use for respiratory illness: Historical and anecdotal record. Documents centuries of use, but is not scientific proof of effectiveness.
Safe and effective for human use: Not established. No published human clinical trials exist.

Why Human Clinical Evidence Is So Limited

Several practical barriers explain why agarikon has not reached human trials, unlike some other medicinal mushroom species.

Rarity. True Fomitopsis officinalis is considered endangered in much of its range because it depends on old-growth conifer forest that has largely disappeared. This makes it very difficult to source enough wild material for research or manufacturing.
Cultivation difficulty. Unlike shiitake or lion’s mane, agarikon has been difficult to cultivate reliably, which limits standardized, consistent extract for trials.
No standardized extract. Clinical trials require a consistent, well-characterized product. Without one, researchers cannot design a trial that produces meaningful, repeatable results.
Funding. Rare, non-patentable natural products historically attract less pharmaceutical research funding than compounds that can be synthesized and patented.

The NCCIH notes more broadly that many herbal and fungal supplements on the market have not been tested in pregnant women, nursing mothers, or children, and that supplement quality can vary by brand and batch because the FDA does not review products before they are sold.

Safety Considerations and Extra-Caution Groups

Because no clinical safety data exists for agarikon specifically, general supplement-safety guidance applies with extra weight here.

People taking prescription medications: Mushroom compounds broadly can interact with blood thinners, immune-modulating drugs, and other medications. Without specific agarikon interaction data, this risk cannot be ruled out or quantified.
People with autoimmune conditions or on immunosuppressive therapy: Many medicinal mushroom compounds affect immune signaling. With no trial data on agarikon’s immune effects in people, this group should be especially cautious.
Pregnant or breastfeeding people: No safety data exists for this population, which is consistent with NCCIH’s general caution that supplements are rarely tested in pregnancy or lactation.
People considering surgery: NCCIH and the NIH Office of Dietary Supplements both recommend disclosing all supplement use to a surgical team, since some supplements can affect bleeding or interact with anesthesia.
Anyone buying a product marketed as “agarikon”: Given the species’ rarity, verifying authenticity and manufacturing quality is difficult. Look for third-party testing (organizations such as NSF International or U.S. Pharmacopeia offer quality-testing seals), though NCCIH notes these seals confirm manufacturing quality, not safety or effectiveness.

If you experience an unexpected reaction to any mushroom supplement, the NIH Office of Dietary Supplements recommends reporting it to the FDA at 800-FDA-1088.

How to Evaluate Agarikon Products If You’re Considering Them

This is an educational checklist, not a recommendation to buy or use any product.

Ask whether the product lists a verifiable species name (Fomitopsis officinalis or Laricifomes officinalis) and whether it discloses fruiting body versus mycelium content.
Look for third-party lab testing results, not just marketing claims.
Be skeptical of any product claiming proven antiviral or antibacterial effects in humans; as this article shows, that evidence does not yet exist.
Talk to a pharmacist or physician about your current medications before adding any new supplement.
Report any adverse reaction to your health care provider and to the FDA.

Frequently Asked Questions

Is agarikon proven to fight viruses or bacteria in humans?

No. Laboratory studies have found antiviral and antibacterial activity against specific viruses and bacteria in cell culture. No human clinical trials have tested whether agarikon prevents or treats infection in people.

Is agarikon the same thing as other well-known medicinal mushrooms like reishi or turkey tail?

No. Agarikon is a distinct, much rarer species with far less research behind it. Species like turkey tail have decades of laboratory and human clinical research, including trials in cancer care settings, while agarikon currently has laboratory data only. See our Turkey Tail research profile for a comparison of what a more studied species looks like.

Is it safe to take agarikon supplements?

This has not been established either way. No published human safety studies or dosing data exist. Anyone considering an agarikon product, especially while pregnant, nursing, immunocompromised, or on medication, should discuss it with a qualified health care provider first.

Why is agarikon so rare and expensive compared to other mushroom supplements?

True agarikon depends on old-growth conifer forest and is considered endangered across much of its range. It has also proven difficult to cultivate reliably, unlike common species such as shiitake or lion’s mane, which limits supply and drives up cost.

Educational Disclaimer

This article is for general educational purposes only. It is not medical advice and should not be used to diagnose, treat, cure, or prevent any disease or condition. It does not recommend that you start, stop, or change any medication or supplement. Always talk with a qualified health care provider before using any mushroom supplement, especially if you are pregnant, nursing, managing a chronic condition, taking medication, or preparing for surgery.